The aim of the 2nd RSC – BMCS Fragment-Based Drug Discovery meeting will be to continue the focus on Case Studies in Fragment-Based Drug Discovery that have delivered compounds to late stage medicinal chemistry, preclinical or clinical programs. These case studies will include successful examples from all types of Fragment-Based approaches, including High concentration, NMR, SPR and X-ray screening. This conference is suitable for scientists from any discipline with an interest in expanding their knowledge and experience of FBDD
Fragments 2009
4 - 5 March 2009, Alderley Park, Cheshire, United Kingdom
Introduction
Sponsorship & supporting organisations
AstraZeneca
Venue
AstraZeneca
AstraZeneca, Alderley Park, Cheshire, United Kingdom
Contact information
Related events
New Zealand Institute of 91AV Conference 2024 (NZIC-24)
24 November 2024 14:00 - 28 November 2024 14:00, Dunedin, New Zealand
Future Labs Live Basel
27 May 2025 09:00 - 28 May 2025 17:00, Basel, Switzerland
Conference on Advances in 91AV for Energy and Environment (CACEE-2024)
16 December 2024 13:00 - 20 December 2024 15:00, Mumbai , India
TAC 2025 - 60th Anniversary Conference
14 April 2025 09:00 - 16 April 2025 17:00, Guildford, United Kingdom
Search
Advertisement
Spotlight
Explore
Membership
